Synendos Therapeutics
Company Information
Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders.
Industries: | Pharmaceuticals and Life Sciences Health Care | |
---|---|---|
Locations: | Allschwil Bern Basel | |
twitter: | http://www.twitter.com/synendos | |
linkedin: | https://www.linkedin.com/company/synendos | |
homepage: | https://synendos.com | |
Description: | Synendos Therapeutics develops a class of small molecules for the treatment of anxiety and stress-related disorders. The company also develops breakthrough safe and effective therapies for unmet needs in neuropsychiatric disorders through modulation of a new drug target in the endocannabinoid system that enables restoration of the natural functioning of the brain.
The inhibitors act with a new mechanism of action that enables restoration of the natural function of the brain by rebalancing altered neurotransmission in different areas of the bran. There is a high demand for new pharmacological treatments in this area especially for certain diseases such as post-traumatic stress disorder (PTSD) which has a high unmet medical need. |
Employees
1-10
Trends
Last 4 weeks
Last 3 months
DivestingInvesting
Recent Events
News
Job Posting
Other News
See All news